With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...

Hepatitis B is one of the most widespread viral infections in the world, with hundreds of millions of people living with it today. Caused by the hepatitis B virus (HBV), this condition primarily ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk patients. Study: AGA Clinical Practice Guideline on the Prevention and Treatment ...

Breaking News: Trump administration impacts continue to roil the life sciences sector Home » Therapeutic hepatitis B vaccine generates robust HBc-specific T-cell responses in preclinical tests ...

Add Yahoo as a preferred source to see more of our stories on Google. About 80% of parents currently choose to follow CDC guidelines to vaccinate their babies for hepatitis B at birth.